Literature DB >> 8265100

Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum.

G B Secco1, R Fardelli, E Campora, G Lapertosa, R Gentile, S Zoli, C Prior.   

Abstract

Of 352 patients with colorectal carcinoma followed for a minimum of 5 years after surgery, 39 cases (11.1%; median age 60 years) had mucinous adenocarcinoma, and 4 (1.1%; median age 62 years) had signet-ring cell carcinoma. Mucinous carcinomas were most frequently located in the rectum (61.5%) and in the sigmoid colon (15.3%) and presented with stage C and D disease in 41 and 15% of the cases, respectively. Disease recurrence was more frequently observed in patients with mucinous (51.7%) or signet-ring lesions (100%) as compared with adenocarcinomas. Five-year survival was 45 (median 48 months), 28 (median 27), and 0% (median 15 months) in patients with adenocarcinomas, mucinous adenocarcinomas, and signet-ring cell carcinomas, respectively (p < 0.05). Mucinous carcinomas of the rectum had had a significantly worse prognosis (5-year survival 17%, median 33 months) as compared with adenocarcinomas of the same site (5-year survival 34%, median 25 months; p < 0.05).

Entities:  

Mesh:

Year:  1994        PMID: 8265100     DOI: 10.1159/000227306

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  31 in total

Review 1.  [The role of cross-sectional imaging in staging of rectal cancer].

Authors:  A O Schäfer; M Langer; T Baumann
Journal:  Chirurg       Date:  2012-05       Impact factor: 0.955

2.  HNPCC-associated synchronous early-stage signet-ring cell carcinomas of colonic origin. A comparative morphological and immunohistochemical study of an intramucosal and a submucosal example.

Authors:  Louise Klarskov; Inge Bernstein; Susanne Holck
Journal:  Virchows Arch       Date:  2008-11-11       Impact factor: 4.064

3.  Colorectal Cancer in Pregnancy: Driven by Pregnancy-Associated Growth Factors?

Authors:  Maria Y Ho; Alessandra Cassano-Bailey; Piotr Czaykowski
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 4.  Signet-ring cell carcinoma of colorectum--current perspectives and molecular biology.

Authors:  Vinod Gopalan; Robert Anthony Smith; Yik-Hong Ho; Alfred King-Yin Lam
Journal:  Int J Colorectal Dis       Date:  2010-08-05       Impact factor: 2.571

5.  Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers.

Authors:  Min-Hoe Chew; Shen-Ann Eugene Yeo; Zhi-Peng Ng; Kiat-Hon Lim; Poh-Koon Koh; Kheng-Hong Ng; Kong-Weng Eu
Journal:  Int J Colorectal Dis       Date:  2010-08-05       Impact factor: 2.571

6.  Elective palliative resection of incurable stage IV colorectal cancer: who really benefits from it?

Authors:  Renato Costi; Davide Di Mauro; Licia Veronesi; Andrea Ardizzoni; Pierfranco Salcuni; Luigi Roncoroni; Leopoldo Sarli; Vincenzo Violi
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

7.  Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival.

Authors:  Tsunekazu Mizushima; Masaya Nomura; Makoto Fujii; Hiroki Akamatsu; Hitoshi Mizuno; Harumi Tominaga; Junichi Hasegawa; Kiyokazu Nakajima; Keigo Yasumasa; Masato Yoshikawa; Toshirou Nishida
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

Review 8.  Colon carcinoma in childhood: review of the literature with four case reports.

Authors:  Gangmi Kim; Seung Hyuk Baik; Kang Young Lee; Hyuk Hur; Byung Soh Min; Chuhl Joo Lyu; Nam Kyu Kim
Journal:  Int J Colorectal Dis       Date:  2012-10-26       Impact factor: 2.571

9.  Clinical presentation predicts the outcome of patients with colon cancer.

Authors:  Offir Ben-Ishay; Zvi Peled; Amira Othman; Eran Brauner; Yoram Kluger
Journal:  World J Gastrointest Surg       Date:  2013-04-27

10.  Overall survival is improved in mucinous adenocarcinoma of the colon.

Authors:  J Hogan; J P Burke; G Samaha; E Condon; D Waldron; P Faul; J Calvin Coffey
Journal:  Int J Colorectal Dis       Date:  2014-01-15       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.